Tags

Type your tag names separated by a space and hit enter

Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels.
Metabolism. 2016 Apr; 65(4):463-74.M

Abstract

OBJECTIVE

Methylglyoxal is known to be associated with the development of nephropathy, retinopathy, and other complications in diabetes. The present study tested the hypothesis that endogenously increased levels of methylglyoxal in diabetes are causally associated with the induction of neuropathic pain.

MATERIALS AND METHODS

Streptozotocin- and methylglyoxal-induced pain models were established in rats, and the anti-nociceptive effects of the methylglyoxal scavenging agents, selective transient receptor potential channel ankyrin 1 (TRPA1) antagonist, and Nav1.8 antagonist were tested.

RESULTS

Systemic injection of streptozotocin in rats induced a prolonged increase in plasma methylglyoxal by approximately 60%, which was correlated with the progressive development of mechanical allodynia and thermal hyperalgesia. Local subcutaneous injection of methylglyoxal into the hindpaw produced dose-dependent and biphasic flinching nociceptive responses, which resembled formaldehyde (formalin)-induced nociception. The local methylglyoxal nociception was significantly blocked by co-injection into the hindpaw of the selective transient receptor potential channel ankyrin 1 (TRPA1) antagonist, A967079, and the Nav1.8 antagonist, A803467. Co-incubation with the methylglyoxal scavengers, aminoguanidine, d-arginine, and metformin, reduced the level of free methylglyoxal by more than 90%, and injection of their incubation solutions into the hindpaw produced negligible (3-17%) nociception. Like the clinically effective anti-diabetic neuropathic pain drug gabapentin, systemic injection of aminoguanidine, d-arginine, and metformin at doses that effectively inhibit paw-injected methylglyoxal-induced nociception significantly blocked streptozotocin-induced mechanical allodynia.

CONCLUSION

Endogenously increased methylglyoxal may mediate diabetic neuropathic pain via activation of both TRPA1 and Nav1.8 expressed on primary afferent sensory neurons, and injection of methylglyoxal into the hindpaw may serve as a simple and robust model for testing the anti-diabetic pain drugs.

Authors+Show Affiliations

King's Laboratory, School of Pharmacy, Shanghai Jiao Tong University, China. Electronic address: windysalad@hotmail.com.King's Laboratory, School of Pharmacy, Shanghai Jiao Tong University, China. Electronic address: 924477302cy@163.com.King's Laboratory, School of Pharmacy, Shanghai Jiao Tong University, China. Electronic address: niangong0912@yahoo.com.King's Laboratory, School of Pharmacy, Shanghai Jiao Tong University, China. Electronic address: yxwang@sjtu.edu.cn.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26975538

Citation

Huang, Qian, et al. "Methylglyoxal Mediates Streptozotocin-induced Diabetic Neuropathic Pain Via Activation of the Peripheral TRPA1 and Nav1.8 Channels." Metabolism: Clinical and Experimental, vol. 65, no. 4, 2016, pp. 463-74.
Huang Q, Chen Y, Gong N, et al. Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels. Metabolism. 2016;65(4):463-74.
Huang, Q., Chen, Y., Gong, N., & Wang, Y. X. (2016). Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels. Metabolism: Clinical and Experimental, 65(4), 463-74. https://doi.org/10.1016/j.metabol.2015.12.002
Huang Q, et al. Methylglyoxal Mediates Streptozotocin-induced Diabetic Neuropathic Pain Via Activation of the Peripheral TRPA1 and Nav1.8 Channels. Metabolism. 2016;65(4):463-74. PubMed PMID: 26975538.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels. AU - Huang,Qian, AU - Chen,Yuan, AU - Gong,Nian, AU - Wang,Yong-Xiang, Y1 - 2015/12/17/ PY - 2015/10/15/received PY - 2015/12/02/revised PY - 2015/12/12/accepted PY - 2016/3/16/entrez PY - 2016/3/16/pubmed PY - 2016/7/28/medline KW - Diabetic neuropathic pain KW - Methylglyoxal KW - Methylglyoxal scavengers KW - Nav1.8 KW - TRPA1 SP - 463 EP - 74 JF - Metabolism: clinical and experimental JO - Metabolism VL - 65 IS - 4 N2 - OBJECTIVE: Methylglyoxal is known to be associated with the development of nephropathy, retinopathy, and other complications in diabetes. The present study tested the hypothesis that endogenously increased levels of methylglyoxal in diabetes are causally associated with the induction of neuropathic pain. MATERIALS AND METHODS: Streptozotocin- and methylglyoxal-induced pain models were established in rats, and the anti-nociceptive effects of the methylglyoxal scavenging agents, selective transient receptor potential channel ankyrin 1 (TRPA1) antagonist, and Nav1.8 antagonist were tested. RESULTS: Systemic injection of streptozotocin in rats induced a prolonged increase in plasma methylglyoxal by approximately 60%, which was correlated with the progressive development of mechanical allodynia and thermal hyperalgesia. Local subcutaneous injection of methylglyoxal into the hindpaw produced dose-dependent and biphasic flinching nociceptive responses, which resembled formaldehyde (formalin)-induced nociception. The local methylglyoxal nociception was significantly blocked by co-injection into the hindpaw of the selective transient receptor potential channel ankyrin 1 (TRPA1) antagonist, A967079, and the Nav1.8 antagonist, A803467. Co-incubation with the methylglyoxal scavengers, aminoguanidine, d-arginine, and metformin, reduced the level of free methylglyoxal by more than 90%, and injection of their incubation solutions into the hindpaw produced negligible (3-17%) nociception. Like the clinically effective anti-diabetic neuropathic pain drug gabapentin, systemic injection of aminoguanidine, d-arginine, and metformin at doses that effectively inhibit paw-injected methylglyoxal-induced nociception significantly blocked streptozotocin-induced mechanical allodynia. CONCLUSION: Endogenously increased methylglyoxal may mediate diabetic neuropathic pain via activation of both TRPA1 and Nav1.8 expressed on primary afferent sensory neurons, and injection of methylglyoxal into the hindpaw may serve as a simple and robust model for testing the anti-diabetic pain drugs. SN - 1532-8600 UR - https://www.unboundmedicine.com/medline/citation/26975538/Methylglyoxal_mediates_streptozotocin_induced_diabetic_neuropathic_pain_via_activation_of_the_peripheral_TRPA1_and_Nav1_8_channels_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0026-0495(15)00367-4 DB - PRIME DP - Unbound Medicine ER -